Search results

… Dr. J.G.J. Hoeijmakers. Jackson Boonstra| 26 June, 2023 NEUROANATOMICAL VARIATION IN PARKINSON’S DISEASE MOTOR SUBTYPES Supervisors: Prof. dr. Yasin Temel, Dr. Ali Jahanshahi; Co-supervisor: Dr. Alard Roebroeck. Mathew Francis | 19 June, 2023 A Comprehensive Study of Corneal Tissue Responses to Customized Surgical Treatments Supervisors: Prof. dr. R.M.M.A. Nuijts, Dr. R. Shetty (Narayana Nethralaya Eye Hospital, Bangalore, India); Co-supervisor: Dr. A.S. Roy (Narayana Nethralaya Foundation, … susceptibility, and highlighting ethical implications Supervisor: Prof. dr. Bart P.F. Rutten; Co-supervisors: Dr. Gunter Kenis, Dr. Laurence C.C. de Nijs. Samantha Baldi| 26 May, 2023 On Connecting Dots: From imaging to stimulating the obsessive-compulsive brain Supervisor: Prof. K.R.J. Schruers; Co-supervisors: Dr. L. Goossens, Dr. T. Schuhmann. Melissa Schepers| 22 May, 2023 PDE4 gene inhibition – a novel approach to treat demyelinating disorders Supervisors: Prof. Dr. Tim Vanmierlo, Prof. … Hubens| 2 September, 2021 Glaucoma biomarkers in aqueous humor and blood. Supervisor: Prof. Dr. C.A.B. Webers; Co-supervisor: Dr. T.G.M.F. Gorgels. Sjors van de Weijer| 1 September, 2021 Digital technology-enabled home health care - Gamification in online cognitive therapies for Parkinson's disease. Supervisor: Prof. Dr. B.R. Bloem, RU Nijmegen; Co-supervisors: Dr. A.A. Duits; Dr. M.L. Kuijf; Dr. N.M. de Vries, RU Nijmegen. Lisanne Canjels| 31 August, 2021 Morphological and functional Magnetic …

… low back pain: efficacy and mechanism Supervisors: Prof. dr. E. Joosten, Prof. dr. J. van Zundert; Co-supervisor: Dr. J.W. Kallewaard Ralf van Mechelen| 16 October, 2023 Preclinical validation of antifibrotic implantables for use in bleb-forming glaucoma surgery Supervisor: Prof. dr. H. Beckers; Co-supervisors: Dr. J. Wolters, Medpace Medical Device B.V., Dr. C. Bertens Mathew Francis| 9 October, 2023 A Comprehensive Study of Corneal Tissue Responses to Customized Surgical Treatments Supervisors: Prof. dr. R. Nuijts, Dr. R. Shetty (Narayana Nethralaya Eye Hospital, Bangalore, India) Co-supervisor: Dr. A.S. Roy (Narayana Nethralaya Foundation, … Hubens| 2 September, 2021 Glaucoma biomarkers in aqueous humor and blood. Supervisor: Prof. Dr. C.A.B. Webers; Co-supervisor: Dr. T.G.M.F. Gorgels. Sjors van de Weijer| 1 September, 2021 Digital technology-enabled home health care - Gamification in online cognitive therapies for Parkinson's disease. Supervisor: Prof. Dr. B.R. Bloem, RU Nijmegen; Co-supervisors: Dr. A.A. Duits; Dr. M.L. Kuijf; Dr. N.M. de Vries, RU Nijmegen. Lisanne Canjels| 31 August, 2021 Morphological and functional Magnetic …

… Dr. J.G.J. Hoeijmakers. Jackson Boonstra| 26 June, 2023 NEUROANATOMICAL VARIATION IN PARKINSON’S DISEASE MOTOR SUBTYPES Supervisors: Prof. dr. Yasin Temel, Dr. Ali Jahanshahi; Co-supervisor: Dr. Alard Roebroeck. Mathew Francis | 19 June, 2023 A Comprehensive Study of Corneal Tissue Responses to Customized Surgical Treatments Supervisors: Prof. dr. R.M.M.A. Nuijts, Dr. R. Shetty (Narayana Nethralaya Eye Hospital, Bangalore, India); Co-supervisor: Dr. A.S. Roy (Narayana Nethralaya Foundation, … susceptibility, and highlighting ethical implications Supervisor: Prof. dr. Bart P.F. Rutten; Co-supervisors: Dr. Gunter Kenis, Dr. Laurence C.C. de Nijs. Samantha Baldi| 26 May, 2023 On Connecting Dots: From imaging to stimulating the obsessive-compulsive brain Supervisor: Prof. K.R.J. Schruers; Co-supervisors: Dr. L. Goossens, Dr. T. Schuhmann. Melissa Schepers| 22 May, 2023 PDE4 gene inhibition – a novel approach to treat demyelinating disorders Supervisors: Prof. Dr. Tim Vanmierlo, Prof. … Hubens| 2 September, 2021 Glaucoma biomarkers in aqueous humor and blood. Supervisor: Prof. Dr. C.A.B. Webers; Co-supervisor: Dr. T.G.M.F. Gorgels. Sjors van de Weijer| 1 September, 2021 Digital technology-enabled home health care - Gamification in online cognitive therapies for Parkinson's disease. Supervisor: Prof. Dr. B.R. Bloem, RU Nijmegen; Co-supervisors: Dr. A.A. Duits; Dr. M.L. Kuijf; Dr. N.M. de Vries, RU Nijmegen. Lisanne Canjels| 31 August, 2021 Morphological and functional Magnetic …

… low back pain: efficacy and mechanism Supervisors: Prof. dr. E. Joosten, Prof. dr. J. van Zundert; Co-supervisor: Dr. J.W. Kallewaard Ralf van Mechelen| 16 October, 2023 Preclinical validation of antifibrotic implantables for use in bleb-forming glaucoma surgery Supervisor: Prof. dr. H. Beckers; Co-supervisors: Dr. J. Wolters, Medpace Medical Device B.V., Dr. C. Bertens Mathew Francis| 9 October, 2023 A Comprehensive Study of Corneal Tissue Responses to Customized Surgical Treatments Supervisors: Prof. dr. R. Nuijts, Dr. R. Shetty (Narayana Nethralaya Eye Hospital, Bangalore, India) Co-supervisor: Dr. A.S. Roy (Narayana Nethralaya Foundation, … Hubens| 2 September, 2021 Glaucoma biomarkers in aqueous humor and blood. Supervisor: Prof. Dr. C.A.B. Webers; Co-supervisor: Dr. T.G.M.F. Gorgels. Sjors van de Weijer| 1 September, 2021 Digital technology-enabled home health care - Gamification in online cognitive therapies for Parkinson's disease. Supervisor: Prof. Dr. B.R. Bloem, RU Nijmegen; Co-supervisors: Dr. A.A. Duits; Dr. M.L. Kuijf; Dr. N.M. de Vries, RU Nijmegen. Lisanne Canjels| 31 August, 2021 Morphological and functional Magnetic …

… 17 March 2015 I6078970 Marloes Smit Master Thesis Master in International and European Tax Law Maastricht University, Faculty of Law Number of words: 22674 Supervisor: Prof. Dr. H.T.P.M. van den Hurk Ending the current income shifting practices of U.S.-based multinational companies, a feasible objective? With special attention to the role of the OECD BEPS Action Plan and the proposals of the United States to reform the U.S. international system of corporate taxation 2 Table of contents 1. … on Base Erosion and Profit Shifting…………………………………………6 1.3 Apple Inc………………………………………………………………………………………7 1.4 Thesis and chapter outline……………………………………………………………………..7 2 THE CURRENT SITUATION FOR US-BASED MULTINATIONALS……………………9 2.1 Taxation of multinational companies…………………………………………………………...9 2.1.1 Worldwide versus territorial taxation and the system of deferral………………………….....9 2.1.2 The U.S. “CFC” regime……………………………………………………………………..10 2.1.3 Anti-deferral regimes: Subpart F income……………………………………………………12 …